Not FDA-approved
Bones & muscles
MK-677 (ibutamoren)
Evidence
Limited human data
Class
Oral ghrelin receptor agonist (small molecule)
KEY TAKEAWAY
MK-677, also called ibutamoren, is a small molecule rather than a peptide. It mimics ghrelin and is taken by mouth. MK-677 is not FDA-approved. Trials showed it raised IGF-1 and lean mass, but it also increased blood sugar and fluid retention.
Written by the Veylo editorial team · Updated
November 2026
What it is
Oral ghrelin receptor agonist (small molecule)
Main uses
Studied for growth hormone deficiency, frailty and muscle loss; sold online for performance
Key fact
MK-677 is not FDA-approved. Trials showed it raised IGF-1 and lean mass, but it also increased blood sugar and fluid retention.
Route
Oral capsule or liquid once a day
Evidence strength
Limited human data
MK-677, also called ibutamoren, is a small molecule rather than a peptide. It mimics ghrelin and is taken by mouth.
It activates the ghrelin receptor, which raises growth hormone and IGF-1 levels.
MK-677 is not FDA-approved. Trials showed it raised IGF-1 and lean mass, but it also increased blood sugar and fluid retention.
Studied for growth hormone deficiency, frailty and muscle loss; sold online for performance.
Increased appetite, water retention, higher fasting blood sugar and insulin resistance are the main concerns.
MK-677 (ibutamoren): see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.